U.S.: FTC, animal health co reach agreement on distribution exclusivity deals
IDEXX Laboratories Inc has signed a Consent Agreement with the Federal Trade Commission to settle an investigation into whether the diagnostics and information technology solutions company had hampered competition. The company specializes in animal health as well as water and milk supply quality. Under terms of the agreement, IDEXX can no longer have exclusive distribution contracts with three veterinary companies at once. The three companies named are MWI Veterinary Supply, Inc., Butler Schein Animal Health and Webster Veterinary. The agreement says that IDEXX can maintain those exclusivity agreements with two at once, however. IDEXX has not admitted to any legal misdoings, and its CEO and chairman Jonathan Ayers said in a statement that the agreement is a “milestone” in resolving the investigation.
Featured News
The Hidden Security Risk Inside Your Company’s AI Tools
Mar 13, 2026 by
CPI
EU’s Largest Economies Push to Reduce Reliance on Foreign Payment Systems
Mar 12, 2026 by
CPI
Warren Presses Amazon for Answers on Pricing Practices for Government Buyers
Mar 12, 2026 by
CPI
EU Antitrust Chief Raises Concerns Over Big Tech Control of AI
Mar 12, 2026 by
CPI
Burson Adds Senior Advisor to Strengthen Competition Team
Mar 12, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece